A clinical study of transdermal contraceptive patch in Thai women

Journal of the Medical Association of Thailand

Volumn 89, Issue SUPPL. 4, 2006, Pages

  Suwanmalee, Othanee ^a   Taneepanichskul, Surasak ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Adverse effects; Satisfaction; Transdermal contraceptive patch

Indexed keywords

CONTRACEPTIVE AGENT; ETHINYLESTRADIOL PLUS NORELGESTROMIN;

ABDOMINAL CRAMP; ACNE; ADULT; APPLICATION SITE REACTION; ARTICLE; BLEEDING; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; BREAST TENDERNESS; CONTROLLED STUDY; DYSMENORRHEA; FEMALE; HEADACHE; HUMAN; MENSTRUAL CYCLE; MENSTRUATION; NAUSEA; NORMAL HUMAN; PATIENT COMPLIANCE; PREGNANCY; SPOTTING; VOMITING;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; CONTRACEPTIVE AGENTS; ETHINYL ESTRADIOL; FEMALE; HUMANS; MIDDLE AGED; NORGESTREL; OXIMES; PATIENT COMPLIANCE; PATIENT SATISFACTION; PROSPECTIVE STUDIES; THAILAND;

EID: 33846697653     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Zieman M. The introduction of a transdermal hormonal contraceptive. Fertil Steril 2002; 77(Suppl 2): S1-2.
2. Burkman RT. The transdermal contraceptive system. Am J Obstet Gynecol 2004; 190: S49-53.
3. Abram LS, Skee D, Natarajan J, Wong F. Pharmacokinetic overview of OrthoEvra™/Evra™. Fertil Steril 2002; 77 (Suppl 2): S3-12.
4. Zieman M, Guillebaud J, Weisberg E, Shagoal GA, Fisher AC, Creasy GW. Contraceptive efficacy and cycle control with the Ortho Evra™/Evra™ transdermal system: the analysis of pooled data. Fertil Steril 2002; 77 (Suppl 2): S13-8.
5. Saibai BM, Odlind V, Meador ML, Shangold GA, Creasy GW. A comparative and pooled analysis of the safety and tolerability of the contraceptive patch (Ortho Evra™/Evra™). Fertil Steril 2002; 77 (Suppl 2): S19-26.
6. Archer DF, Bigrigg A, Smallwood GH, Shangold GA, Creasy GW, Fisher AC. Assessment of compliance with a weekly contraceptive patch (Ortho Evra™/Evra™) among North American Women. Fertil Steril 2002; 77 (Suppl 2): S27-31.
7. Zacur HA, Hedon B, Mansour D, Shangold GA, Fisher AC, Creasy GW. Integrated summary of Ortho Evra™/Evra™ contraceptive patch adhesion in varied climates and conditions. Fertil Steril 2002; 77 (Suppl 2): S32-5.
8. Audet MC, Moreau M, Koitun WD, Waldbaum AS, Shangold G, Fisher AC. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive:a randomized controlled trial. JAMA 2001; 285: 2347-54.
9. Smallwood GH, Meador ML, Lenihan JP, Shangoid GA, Fisher AC, Creasy GW. Efficacy and safety of transdermal contraceptive system. Obstet Gynecol 2001; 98: 799-805.
10. Rubinstein ML, Halpern-Felsher BL, Irwin CE. An evaluation of the contraceptive patch in adolescents. J Aldolescent health 2004;34: 395-401.
11. Dittrich R, Parker L, Rosen JB, Shangold G, Creasy GW, Fisher AC, et al. Transdermal contraceptive: evaluation of three transdermal norelgestromin/ ethinyl estradiol doses in a randomized multicenter dose-response study. Am J Obstet Gynecol 2002; 186: 15-20.
12. White T, Jain JK, Stanczyx FZ. Effect of oral versus transdermal steroidal contraceptives on androgenic markers. Am J Obstet Gynecol 2005; 192: 2055-9.